The problem of cytomegalovirus (CMV) prophylaxis in high-risk renal transplant recipients.
Maiwald
J
J
Sperschneider
H
H
Stein
G
G
D000914:Antibodies, Viral / Q000097:blood / Q000494:pharmacology; D000998:Antiviral Agents / Q000494:pharmacology; D003586:Cytomegalovirus Infections / Q000276:immunology / Q000517:prevention & control*; D015774:Ganciclovir / Q000494:pharmacology; D005858:Germany; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007136:Immunoglobulins / Q000494:pharmacology; D016030:Kidney Transplantation / Q000009:adverse effects*; D012307:Risk Factors; D011795:Surveys and Questionnaires
D000914:Antibodies, Viral; D000998:Antiviral Agents; D007074:Immunoglobulin G; D007136:Immunoglobulins; D015774:Ganciclovir